ADC Therapeutics (ADCT) Deferred Taxes (2022 - 2023)
Historic Deferred Taxes for ADC Therapeutics (ADCT) over the last 2 years, with Q4 2023 value amounting to $42.9 million.
- ADC Therapeutics' Deferred Taxes rose 275604.76% to $42.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $37.1 million, marking a year-over-year increase of 238895.74%. This contributed to the annual value of $37.1 million for FY2023, which is 238895.74% up from last year.
- Per ADC Therapeutics' latest filing, its Deferred Taxes stood at $42.9 million for Q4 2023, which was up 275604.76% from -$578000.0 recorded in Q3 2023.
- In the past 5 years, ADC Therapeutics' Deferred Taxes registered a high of $42.9 million during Q4 2023, and its lowest value of -$5.1 million during Q2 2023.